Summary of clinical results

DUCRAY
Keracnyl serum

Tolerance of KERACNYL serum in combination with topical anti-acne treatments

Tolerance of KERACNYL serum in combination with topical anti-acne treatments, under dermatological control

Population

39 adult women with mild to moderate facial acne treated with stable topical acne therapy for at least 2 weeks (Retinoids or derivatives, Epiduo®, Benzoyl peroxide)

 

Application of KERACNYL serum

Application twice a day (morning/evening) to the entire face for 4 weeks

 

Evaluation criteria

  • Skin tolerance
  • Evolution of physical and functional signs of skin intolerance to anti-acne treatments

 

Results

After 14 days and 28 days of use, significant decrease in physical signs:

  • Redness (p=0.001)
  • Flaking (p=0.0005)
  • Dryness (p<0.0001)
     

After 28 days, significant decrease in functional signs:

  • Burning (p=0.002)
  • Overheating (p=0.0009)
  • Pruritus (p=0.0078)
  • Tightness (p<0.0001)
  • Tingling (p=0.0039)

 

Conclusion

  • Tolerance tested in combination with leading topical acne treatments
  • From 14 days, compensation for the skin side effects of treatments

More summaries of clinical results